Gianna is an associate editor of The American Journal of Managed Care® (AJMC®). She has been working on AJMC® since 2019 and has a BA in philosophy and journalism & professional writing from The College of New Jersey.
Study Finds IWG 2006 Response Criteria Valid in Patients With Higher-Risk MDS
Complete response to first-line therapy, as determined by the International Working Group 2006 response criteria, can be used as a surrogate end point for overall survival in higher-risk patients with myelodysplastic syndromes (MDS), according to a study published in Cancer Medicine.
Deep Learning Model Detects Sea Fan Neovascularization in Patients With Sickle Cell Hemoglobinopathy
In an effort to detect sea fan neovascularization from ultra-widefield color fundus photographs from patients with sickle cell hemoglobinopathy, researchers developed an automated system with high sensitivity and specificity, which holds potential to improve screening for vision-threatening proliferative sickle cell retinopathy.
Study Compares Vertigo’s Effects on Patients With Vestibular Migraine, BPPV
The emotional, functional and physical effects of vertigo on patients with vestibular migraine were shown to be more significant compared with the experiences of patients with benign paroxysmal positional vertigo (BPPV) in a recent study.
Decreased Retinal Vessel, Perfusion Densities Found in Those With Parkinson Disease
Results from a cross-sectional study show individuals with Parkinson disease exhibited decreased retinal vessel and perfusion density, as well as choroidal structural changes compared with age- and sex-matched controls.
Infant Cataract Surgery Increases Long-Term Glaucoma Risk, Regardless of IOL Implants
Among children who underwent unilateral cataract removal in infancy, risk of glaucoma-related adverse events continues to increase with longer follow-up and is not associated with primary intraocular lens (IOL) implementation, according to research published in JAMA Ophthalmology.
Top 5 Most-Read Ophthalmology Stories of 2020
In a year in which health care professionals were forced to alter treatment plans to adjust to an ongoing health crisis, the majority of our most popular ophthalmology stories of 2020 involved the intersection of ophthalmologic care and coronavirus disease 2019.
Top 5 Most-Popular Managed Care Cast Episodes of 2020
The top 5 most listened-to podcasts spanned a range of health topics, including key 2020 election concerns among stakeholders, the use of applied machine learning to predict health care utilization, and real-world evidence on biomarker testing in colon cancer.
Study to Measure Patient-Reported Outcomes Before and After Minimally Invasive Glaucoma Surgery
Verana Health, along with the FDA, the American Glaucoma Society, and American Academy of Ophthalmology, recently announced the launch of the Patient-Reported Outcomes for Minimally Invasive Glaucoma Surgery study with the first patient enrolled.
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.
Review Details Relationship Between Frailty, Diabetes in Older Populations
The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Review Outlines Pharmacists’ Role in Migraine Management
In a recently published review, researchers highlighted the disease burden of migraine, advances in preventive therapies, key takeaways from the most recent migraine management consensus statement, and advocated for increased pharmacist intervention in migraine medication management.